Results for tag: "Oligonucleotide Therapy"

Oligonucleotide Therapy is a type of oncology drug that uses short strands of nucleic acids to target and treat cancer. It works by targeting specific genes or proteins that are involved in the development and progression of cancer. Oligonucleotide Therapy can be used to inhibit the expression of oncogenes, activate tumor suppressor genes, or target specific proteins that are involved in cancer cell growth and survival. It can also be used to deliver therapeutic agents directly to cancer cells. Oligonucleotide Therapy has the potential to be more effective and less toxic than traditional chemotherapy and radiation treatments. It is also more specific, allowing for targeted treatment of cancer cells while leaving healthy cells unharmed. Some companies in the Oligonucleotide Therapy market include Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, and Ionis Pharmaceuticals. Show Less Read more